Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer Trials

J Natl Cancer Inst. 2021 May 4;113(5):507-508. doi: 10.1093/jnci/djaa135.

Authors

Affiliations

¹ Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
² Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.

No abstract available

MeSH terms

Humans
Neoplasms* / drug therapy
Neoplasms* / epidemiology